Cigarette smoking is associated with chronic obstructive pulmonary disease and chronic
bronchitis. Acquired ion transport abnormalities, including cystic fibrosis transmembrane …

Background The potential for adverse respiratory effects following exposure to electronic (e-)
cigarette liquid (e-liquid) flavorings remains largely unexplored. Given the multitude of flavor …

Chronic bronchitis, a disease mainly of cigarette smokers, shares many clinical features with
cystic fibrosis, a disease of altered ion transport, suggesting that the negative effects of …

Electronic (e)-cigarettes theoretically may be safer than conventional tobacco. However, our
prior studies demonstrated direct adverse effects of e-cigarette vapor (EV) on airway cells …

Cigarette smoking is known to disrupt the normal mucociliary function of the lungs, whereas
the effect of electronic nicotine delivery systems (ENDS) is not completely understood. This …

Chronic obstructive pulmonary disease affects 64 million people and is currently the fourth
leading cause of death worldwide. Chronic obstructive pulmonary disease includes both …

E-cigarettes are generally thought of as a safer smoking alternative to traditional cigarettes.
However, little is known about the effects of e-cigarette liquids (e-liquids) on the lung. Since …

Rationale: Several extrapulmonary disorders have been linked to cigarette smoking.
Smoking is reported to cause cystic fibrosis transmembrane conductance regulator (CFTR) …

Cigarette smoke (CS) exposure induces mucus obstruction and the development of chronic
bronchitis (CB). While many of these responses are determined genetically, little is known …

Background Exposure to electronic-cigarette (e-cig) aerosols induces potentially fatal e-cig
or vaping-associated lung injury (EVALI). The cellular and molecular mechanisms …